|
Real-time Estimate
Cboe BZX
10:37:35 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 38.26 USD | -3.52% |
|
-9.63% | +27.13% |
| 08-05 | Rapport Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-28 | William Blair Initiates Rapport Therapeutics at Outperform | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.52% | -9.63% | -21.81% | +1.00% | +27.13% | +47.72% | - | - | - | 1.9B | |
| +2.37% | +4.17% | -4.80% | +11.83% | +4.05% | +3.48% | +31.27% | -26.12% | +203.14% | 46.68B | |
| -0.25% | +0.10% | +3.72% | +60.85% | +19.75% | +43.71% | +35.81% | +3.92% | +245.49% | 44.42B | |
| +0.64% | -5.92% | -8.91% | +16.23% | +141.96% | +333.97% | +542.42% | +506.43% | - | 41.32B | |
| -0.95% | +4.16% | -2.98% | +32.79% | +18.79% | +6.84% | +89.37% | -7.03% | +1,057.50% | 41.58B | |
| +1.11% | +1.45% | -5.67% | +6.52% | +5.23% | +11.52% | +45.96% | -19.91% | +134.89% | 30.14B | |
| -0.38% | +0.56% | +0.64% | +36.94% | +11.10% | +25.28% | +157.11% | +227.10% | +1,983.42% | 17.42B | |
| +0.61% | -0.69% | -5.49% | +4.44% | - | - | - | - | - | 15.6B | |
| +0.79% | +7.08% | +7.40% | +23.94% | +26.09% | +25.53% | +43.42% | -36.86% | +90.62% | 15.54B | |
| -0.33% | +14.38% | +19.01% | +64.58% | +33.36% | -8.29% | - | - | - | 14.08B | |
| +1.78% | +4.36% | -4.62% | +56.86% | +42.77% | +85.06% | +42.67% | -36.19% | +243.29% | 13.32B | |
| -0.30% | -2.24% | -2.82% | +19.80% | -7.48% | -1.29% | -32.67% | -38.56% | +120.44% | 13.08B | |
| +0.10% | +0.28% | +0.21% | +30.45% | +23.35% | +36.77% | +4.61% | -45.56% | +164.98% | 11.36B | |
| +4.23% | +5.81% | -5.94% | +98.72% | +58.74% | +28.91% | +64.41% | -54.06% | - | 11.35B | |
| +2.90% | +6.15% | -0.78% | +20.77% | +54.36% | +135.45% | +586.31% | +92.63% | - | 9.78B | |
| +1.10% | +2.17% | -5.31% | +27.36% | +67.74% | +127.10% | +756.25% | +847.03% | +812.80% | 9.38B | |
| -5.52% | -8.74% | -12.69% | -0.17% | -28.86% | +23.41% | +428.05% | +166.41% | +899.42% | 9.06B | |
| -1.60% | +3.86% | +5.60% | +21.61% | -6.80% | -8.34% | +0.27% | -27.80% | +41.66% | 9.26B | |
| +1.59% | -3.24% | -17.73% | -0.21% | +2.72% | +526.45% | +1,301.69% | +1.02% | - | 8.34B | |
| +0.11% | +1.28% | -14.31% | -2.57% | +46.03% | +138.10% | +82.05% | +324.71% | - | 7.68B | |
| Average | +0.20% | +0.85% | -3.86% | +26.59% | +28.42% | +83.23% | +245.82% | +110.42% | +499.80% | 18.57B | |
| Weighted average by Cap. | +0.46% | +1.42% | -2.68% | +28.55% | +32.65% | +76.78% | +185.75% | +96.72% | +487.03% |
- Stock Market
- Stocks
- RAPP Stock
- Sector Rapport Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
